Glioblastoma of the Brain. Financial and Economic Aspects of Therapy. Literature Review

Abstract

Malignant brain tumors include primary and metastatic brain tumors. The incidence and prevalence of malignant tumors of the central nervous system (CNS) around the world continue to grow. Treatment of this group of patients requires complex and expensive diagnostic and therapeutic technologies. Thus, malignant brain tumors, whether primary or metastatic, have a significant socio-economic impact on patients, their families and healthcare systems around the world. At the moment, there is no systematic review of the costs of treating patients with brain tumors, although some studies emphasize the importance of this problem.